Baxter International Inc.

NYSE:BAX

Medical - Instruments & Supplies

Healthcare
$26.16 -5.23%

-$1.07 today

Market cap
$13.53B
Beta
0.64
P/E (TTM)
-9.1
EPS (TTM)
-$2.13
Dividend yield
1.03%
52W Low $15.73High $31.76

Volume 4.01M

Average 7.62M

BAX Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Baxter International Inc.NYSE: BAX

Net Change in Cash · Q2 FY2026 · quarter ended Jun 2026

Net change in cash turns positive

Q2 FY2026 net change in cash was $137M, compared with -$608M a year earlier. Trailing-twelve-month net change in cash was $466M. Over 3 fiscal years it compounded at -28.8% a year.

Context

  • Net change in cash amounted to 4.0% of revenue in FY2025, down 3.4 pp from a year earlier.
  • Net change in cash increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly net change in cash holds near $137M or moves back toward the trailing-twelve-month quarterly average of $116.5M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$137M+179.6% QoQ
Last fiscal yearDec 2025
-$446M-43.1% YoY
LTMJun 2026
$466M+214.2% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+122.5%——
1 year-43.1%——
3-year CAGR-28.8%——
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(446M) USD
Year-over-year change
+43.1%

Net Change in Cash vs competitors

How BAX compares with its peers on the latest reported figures

  • Peers report in different currencies, so net change in cash is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +214.2% is the highest of 5, against a peer median of -74.8%.
  • Net change in cash amounts to 4.1% of revenue for BAX, versus a peer median of 0.4%.
BAX Competitors
Net Change in Cash for BAX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€659.35M EUR-208.4%—3.4%
BAXBaxter International Inc.LTM Jun 2026$466M USD+214.2%-28.8%4.1%
DVADaVita Inc.LTM Jun 2026$45.1M USD-115.4%-17.3%0.3%
ICUIICU Medical, Inc.LTM Jun 2026$1.73M USD-34.2%-87.9%0.1%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$600K USD-12.3%—0.4%
Peer median (excluding BAX) —-74.8%-52.6%0.4%

Competitors are the stored peer set for BAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.03B(3.11B)181M(326M)(957M)
Depreciation & Amortization867M1.07B984M997M981M
Deferred Income Tax(161M)(260M)(256M)(262M)77M
Stock-Based Compensation146M140M115M114M117M
Change in Working Capital(57M)(606M)161M(236M)(108M)
Accounts Receivables(170M)(48M)(38M)(35M)(132M)
Inventory(27M)(198M)(128M)(201M)(119M)
Accounts Payables105M(67M)92M112M3M
Other Working Capital35M(293M)235M(112M)140M
Other Non-Cash Items394M3.98B541M732M735M
Operating Cash Flow2.22B1.21B1.73B1.02B845M
Capital Expenditures(691M)(635M)(436M)(460M)(522M)
Acquisitions (Net)(10.5B)(263M)(6M)00
Purchases of Investments00000
Sales of Investments00034M0
Other Investing Activities(7M)(33M)3.66B(200M)3.35B
Investing Cash Flow(11.2B)(931M)3.21B(626M)2.84B
Debt Repayment9.33B(899M)(2.94B)(531M)(3.79B)
Common Stock Issued187M127M95M71M30M
Common Stock Repurchased(600M)(32M)000
Dividends Paid(530M)(573M)(586M)(590M)(348M)
Other Financing Activities(138M)(61M)(63M)(31M)(107M)
Financing Cash Flow8.25B(1.44B)(3.49B)(1.08B)(4.22B)
Effect of Forex Changes(47M)(76M)26M(96M)84M
Net Change in Cash(780M)(1.23B)1.48B(784M)(446M)
Free Cash Flow1.53B576M1.29B559M323M

Baxter International Inc.

NYSE:BAX

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.